Both Semaglutide GLP-1 and Zepbound are intended for long-term usage in medical weight management
10.1007/s00125-004-1498-0 36 RobertK.VialardF.ThieryE.ToyamaK.SinetP.JanelN.et al
From weight loss breakthroughs to type 2 diabetes management , and even anti-aging medicine , these treatments offer extraordinary promise
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Massollo M, Marini C, Brignone M, et al
Originally developed for managing type 2 diabetes, semaglutide GLP-1 has shown exceptional results in reducing body weight, leading to its approval for this purpose
For example, conditions such as thyroid disorders , polycystic ovary syndrome (PCOS) , and insulin resistance can affect how well these medications manage appetite and metabolism